uniQure (QURE) EBT Margin Growth (3y) (2019 - 2026)
uniQure (QURE) EBT Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | -1,631.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,631.00 |
| Dec 31, 2025 | -74,281.00 |
| Sep 30, 2025 | 138,267.00 |
| Jun 30, 2025 | 721,460.00 |
| Mar 31, 2025 | -11,392.00 |
| Dec 31, 2024 | -140,044.00 |
| Sep 30, 2024 | -10,962.00 |
| Jun 30, 2024 | -58,431.00 |
| Mar 31, 2024 | 834,078.00 |
| Dec 31, 2023 | -99,885.00 |
| Sep 30, 2023 | -336,513.00 |
| Jun 30, 2023 | -4,839.00 |
| Mar 31, 2023 | 2.54 Mn |
| Dec 31, 2022 | 158,456.00 |
| Sep 30, 2022 | -106,887.00 |
| Jun 30, 2022 | -665,418.00 |
| Mar 31, 2022 | -19,446.00 |
| Dec 31, 2021 | 153,988.00 |
| Sep 30, 2021 | -113,119.00 |
| Jun 30, 2021 | 75,013.00 |